Literature DB >> 28767341

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.

William J Sandborn1, Chinyu Su2, Julian Panes3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28767341     DOI： 10.1056/NEJMc1707500

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  26 in total

Review 1.  Cutaneous Manifestations of Reactions to Biologics.

Authors:  Iris M Otani; Amy S Levin; Aleena Banerji
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-21       Impact factor: 4.806

2.  Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function.

Authors:  Caroline H T Hall; J Scott Lee; Emily M Murphy; Mark E Gerich; Rachael Dran; Louis E Glover; Zuhair I Abdulla; Matthew R Skelton; Sean P Colgan
Journal:  Gastroenterology       Date:  2020-05-17       Impact factor: 22.682

Review 3.  IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets.

Authors:  Doha Anka Idrissi; Nezha Senhaji; Asmae Aouiss; Loubna Khalki; Youssef Tijani; Nabil Zaid; Fatima Zahra Marhoume; Abdallah Naya; Mounia Oudghiri; Mostafa Kabine; Younes Zaid
Journal:  Arch Pharm Res       Date:  2021-01-04       Impact factor: 4.946

4.  Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets.

Authors:  Federica Crispino; Mauro Grova; Erica Maria Bruno; Noemi Monachino; Giuseppe Rizzo; Angelo Casà; Sara Renna; Fabio Salvatore Macaluso; Ambrogio Orlando
Journal:  Drugs       Date:  2022-07-28       Impact factor: 11.431

Review 5.  Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.

Authors:  Torsten Kucharzik; Sibylle Koletzko; Klaus Kannengiesser; Axel Dignass
Journal:  Dtsch Arztebl Int       Date:  2020-08-17       Impact factor: 5.594

Review 6.  Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More.

Authors:  Philipp Schreiner; Markus F Neurath; Siew C Ng; Emad M El-Omar; Ala I Sharara; Taku Kobayashi; Tadakazu Hisamatsu; Toshifumi Hibi; Gerhard Rogler
Journal:  Inflamm Intest Dis       Date:  2019-07-09

7.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

8.  Trends in corticosteroid prescriptions for ulcerative colitis and factors associated with long-term corticosteroid use: analysis using Japanese claims data from 2006 to 2016.

Authors:  Katsuyoshi Matsuoka; Ataru Igarashi; Noriko Sato; Yuri Isono; Maki Gouda; Katsuhiko Iwasaki; Ayako Shoji; Tadakazu Hisamatsu
Journal:  J Crohns Colitis       Date:  2020-08-26       Impact factor: 9.071

9.  Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.

Authors:  Scott David Lee; Anand Singla; Jason Harper; Mitra Barahimi; Jeffrey Jacobs; Kendra J Kamp; Kindra Dawn Clark-Snustad
Journal:  Inflamm Bowel Dis       Date:  2022-02-01       Impact factor: 7.290

10.  Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.

Authors:  Kai-Jun Zhu; Pei-Dan Yang; Qiang Xu
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.